UBS Group
PBH icon

UBS Group’s Prestige Consumer Healthcare PBH Stock Holding History

UBS Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$56K – 7893
2017
Q1 		$56K Hold
1,000
– – ﹤0.01% 5438
2016
Q4 		$52K Sell
1,000
-1,000
-50% -$48.3K ﹤0.01% 5800
2016
Q3 		$97K Buy
+2,000
New +$101K ﹤0.01% 5013

Other funds holding PBH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $33.9B AUM 47.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $26.8B AUM 3.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

UBS Group's PBH Position: Q3 2026 in Review

UBS Group reduced its Prestige Consumer Healthcare (PBH) stake by 8.3% in Q3 2026, selling an estimated $2.64M and leaving 585,606 shares worth $26.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2345.

UBS Group first reported a position in PBH in Q4 2014 and has held it in 48 quarters since. The position peaked at $30.6M in Q2 2025. 266 funds tracked by Wall St. Rank hold PBH as of Q3 2026.

  • UBS Group held 585,606 shares of Prestige Consumer Healthcare worth $26.9M as of Q3 2026.
  • UBS Group sold 52,999 Prestige Consumer Healthcare shares in Q3 2026, an estimated $2.64M.
  • Prestige Consumer Healthcare made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2345 holding.
  • UBS Group first reported a position in Prestige Consumer Healthcare in Q4 2014 and has held it in 48 quarters since.
  • UBS Group's Prestige Consumer Healthcare position peaked at $30.6M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.